Clinical trial
Bevacizumab, Fluorouracil, and External-Beam Radiation Therapy in Treating…
NCT00052559 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00052559 |
|---|---|
| Title | Bevacizumab, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer |
| Official title | A Phase I Study Of The Antiangiogenic Agent Bevacizumab In Combination With 5-Fluourouracil And External Beam Radiation Therapy In Rectal Cancer |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer |
| Intervention type | Biological, Drug, Other, Procedure, Radiation |
| Interventions | bevacizumab, fluorouracil, external beam radiation therapy, therapeutic conventional surgery, laboratory biomarker analysis |
| Enrollment | 32 |
| Start date | Aug 1, 2002 |
| Primary completion | Apr 1, 2003 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 5, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: